Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2016 Oct;75(4):698-705.
doi: 10.1016/j.jaad.2016.05.011. Epub 2016 Jul 16.

Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study

Erin X Wei  1 , Abrar A Qureshi  2 , Jiali Han  3 , Tricia Y Li  4 , Eunyoung Cho  2 , Jennifer Y Lin  5 , Wen-Qing Li  6
Affiliations
Observational Study

Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study

Erin X Wei et al. J Am Acad Dermatol. 2016 Oct.

Abstract

Background: The incidence of melanoma in situ (MIS) is increasing, but little is known about its clinical and epidemiologic features.

Objective: We sought to determine trends in diagnosis and clinical features of MIS.

Methods: Incident cases of melanoma were collected prospectively from the Nurses' Health Study (1976-2010) and Health Professionals Follow-up Study (1986-2010).

Results: MIS incidence increased from 2 to 42 per 100,000 person-year among women, and from 11 to 73 per 100,000 person-year among men, exceeding the rate of increase of invasive melanomas. Melanoma mortality initially increased during the follow-up period then plateaued. Men were more likely than women to develop in situ melanomas on the upper half of the body (P < .001). Invasive melanomas were diagnosed at a younger age than MIS (P < .001), and were more likely to be found on the lower extremities than MIS (P < .001).

Limitations: This is a strictly descriptive study without examination into mechanisms.

Conclusion: We found epidemiologic and clinical differences for in situ and invasive melanomas, which support further examination into the variations in etiologic pathways. The lack of improvement in mortality despite the increase in detection of in situ relative to invasive lesions further highlights the need to improve invasive melanoma-specific clinical screening features.

Keywords: age; anatomic sites; epidemiology; gender; incidence; invasive malignant melanoma; lentigo maligna; melanoma; melanoma in situ; melanoma screening; occupational cohorts.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Age-adjusted incidence of melanoma overall, MIS and IMM in (A) women (NHS) and (B) men (HPFS) during the follow-up period
Figure 1 shows that MIS incidence increased over the follow-up period among both women and men; the incidence of MIS increased at a greater rate than that of IMM. For women, the absolute incident cases of MIS first exceeded that of IMM during 2001–02. Among men, the absolute incident cases of MIS first exceeded that of IMM during 2007–08. *MIS, melanoma in situ; IMM, invasive malignant melanoma
Figure 2
Figure 2. Distribution in anatomic sites of MIS and IMM in women (NHS) and men (HPFS)
Figure 2 shows that among men diagnosed with MIS, 39% of lesions were found on the head and neck, 40% on the trunk, 15% on the upper extremities, and 6% on lower extremities, whereas in men diagnosed with IMM, 23% were found on the head and neck, 51% on the trunk, 14% on the upper extremities, 12% on the lower extremities. Among women, 25% of MIS were found on the head and neck, 29% on the trunk, 26% on the upper extremities, 21% on lower extremities, compared to IMM, where 10% were found on the head and neck, 31% on the trunk, 25% on the upper extremities, 34% on the lower extremities. (Illustrations by Iris Fung) *MIS, melanoma in situ; IMM, invasive malignant melanoma
See this image and copyright information in PMC

References

    1. Mihm MC, Jr, Fitzpatrick TB, Brown MM, Raker JW, Malt RA, Kaiser JS. Early detection of primary cutaneous malignant melanoma. A color atlas. The New England journal of medicine. 1973;289(19):989–996. - PubMed
    1. Criscione VD, Weinstock MA. Melanoma thickness trends in the United States, 1988–2006. The Journal of investigative dermatology. 2010;130(3):793–797. - PubMed
    1. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982–2002. Cancer causes & control : CCC. 2006;17(1):21–27. - PubMed
    1. Thorn M, Ponten F, Johansson AM, Bergstrom R. Rapid increase in diagnosis of cutaneous melanoma in situ in Sweden, 1968–1992. Cancer detection and prevention. 1998;22(5):430–437. - PubMed
    1. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. The Journal of investigative dermatology. 2009;129(7):1666–1674. - PMC - PubMed

Publication types

MeSH terms